Intervention1: Guaifenesin and Dextromethorphan Hydrobromide Extended Release Tablets 1200 mg / 60 mg: A Single oral dose of Guaifenesin and Dextromethorphan Hydrobromide Extended Release Tablets 1200
Sponsors
Marksans Pharma Limited
Unknown Phase
An Open Label Single Dose Oral Bioequivalence Study Comparing Guaifenesin and Dextromethorphan Hydrobromide Extended Release Tablets 1200 mg by 60 mg in Healthy Adult Human Subjects Under Fasting Conditions
Active, not recruitingCTRI/2026/02/104973
Target: 42Updated: 2026-06-01
A Single Dose Oral Bioequivalence Study Comparing Guaifenesin and Dextromethorphan Hydrobromide Tablets 1200 mg / 60 mg in Healthy Adult Human Subjects Under Fed Conditions
RecruitingCTRI/2026/03/105747
Target: 60Updated: 2026-06-01